---
{"dg-publish":true,"permalink":"/USMLE/GI/Primary biliary cholangitis/"}
---

# Etiology
---
- PBC is considered an autoimmune disease
- Often associated with other autoimmune conditions, e.g.: 
	- CREST syndrome
	- Sicca syndrome
	- <span style="background:rgba(240, 200, 0, 0.2)">Autoimmune thyroid disease, especially [[USMLE/Endocrine/Hashimoto thyroiditis\|Hashimoto thyroiditis]]</span>
	- [[USMLE/GI/Celiac disease\|Celiac disease]]
	- [[USMLE/MSK/Rheumatoid arthritis\|Rheumatoid arthritis]]
# Pathophysiology
Inflammation and progressive destruction (<span style="background:rgba(240, 200, 0, 0.2)">likely due to an autoimmune reaction</span>) of the <span style="background:rgba(240, 200, 0, 0.2)">small and medium-sized intrahepatic bile ducts (progressive ductopenia)</span> → defective bile duct regeneration → <span style="background:rgba(240, 200, 0, 0.2)">chronic cholestasis</span> → secondary hepatocyte damage due to increased concentration of toxins that typically get excreted via bile → gradual portal and periportal fibrotic changes → liver failure → liver [[USMLE/GI/Cirrhosis\|cirrhosis]] and portal hypertension (in advanced stage)

# Clinical features
---
>[!tip] Clinical features of PBC
>Similar to PSC + xanthomas and xanthelasma

Patients with PBC are usually initially asymptomatic. 
- <span style="background:rgba(240, 200, 0, 0.2)">Fatigue</span>: most common and often the first symptom
- <span style="background:rgba(240, 200, 0, 0.2)">Marked pruritus: generalized</span>
- Symptoms of cholestasis
	- Jaundice
	- Pale stool, dark urine
	- <span style="background:rgba(240, 200, 0, 0.2)">Maldigestion (more common in advanced disease)</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Deficiency of fat-soluble vitamins (A, D, E, and K)</span>
- Signs of cirrhosis and portal hypertension
	- Hepatomegaly with dull lower margin, RUQ discomfort
	- Splenomegaly
- Hyperpigmentation
	- Due to increased amounts of melanin; the exact cause and pathomechanism remain unclear.
- Xanthomas and xanthelasma 

# Diagnostics
---

<div class="transclusion internal-embed is-loaded"><a class="markdown-embed-link" href="/USMLE/REVIEW/Autoimmune Liver Diseases/" aria-label="Open link"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-link"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a><div class="markdown-embed">





| Feature          | Primary Sclerosing Cholangitis (PSC)                                                      | Primary Biliary Cholangitis (PBC)                                                     | Autoimmune Hepatitis (AIH)                                                 |
| :--------------- | :---------------------------------------------------------------------------------------- | :------------------------------------------------------------------------------------ | :------------------------------------------------------------------------- |
| **Patho**        | Inflammation/fibrosis of **intra- & extrahepatic** bile ducts                             | Autoimmune destruction of **intrahepatic** bile ducts                                 | Autoimmune destruction of **hepatocytes**                                  |
| **Epi / Assoc.** | **M** > F (2:1), <40s<br>Assoc: **[[USMLE/GI/Ulcerative colitis\|Ulcerative Colitis]] (IBD)** (>80%)                       | **F** >> M (9:1), 40-60s<br>Assoc: **Sjögren's**, other autoimmune dz                 | **F** > M (3:1), bimodal (young/middle-aged)<br>Assoc: Other autoimmune dz |
| **Labs**         | Cholestatic: **↑↑ [[USMLE/Blood/Alkaline phosphatase\|ALP]]**, ↑ GGT                                                            | Cholestatic: **↑↑ [[USMLE/Blood/Alkaline phosphatase\|ALP]]**, ↑ GGT                                                        | Hepatocellular: **↑↑↑ AST/ALT** (>1000s common), ↑ IgG                     |
| **Serology**     | **(+) [[USMLE/Immunology/Antineutrophil cytoplasmic antibodies\|p-ANCA]]**                                                                            | **(+) AMA** (Anti-Mitochondrial Ab)                                                   | **(+) ANA**, **(+) ASMA** (Anti-Smooth Muscle Ab)                          |
| **Dx / Histo**   | **MRCP/ERCP**: **"Beads on a string"**<br>Histo: **"Onion skinning"** periductal fibrosis | Normal imaging<br>Histo: **Florid duct lesion** (lymphocytic cholangitis, granulomas) | Normal/nonspecific imaging<br>Histo: **Interface hepatitis**, plasma cells |
| **Tx**           | Symptomatic Tx; Liver transplant (definitive)                                             | **Ursodeoxycholic acid (UDCA)**                                                       | **[[USMLE/Pharmacology/Corticosteroids\|Corticosteroids]]**, Azathioprine                                          |
| **Key Risk**     | **Cholangiocarcinoma**, [[USMLE/GI/Colorectal cancer\|Colorectal Cancer]] (w/ [[USMLE/GI/Ulcerative colitis\|UC]])                                         | [[USMLE/MSK/Osteoporosis\|Osteoporosis]], [[USMLE/GI/Cirrhosis\|Cirrhosis]], HCC                                                          | [[USMLE/GI/Cirrhosis\|Cirrhosis]], Acute Liver Failure                                             |

![Pasted image 20231016163207.png](/img/user/appendix/Pasted%20image%2020231016163207.png)


</div></div>


- Liver chemistries: cholestatic pattern of injury
	- <span style="background:rgba(240, 200, 0, 0.2)">↑ [[USMLE/Blood/Alkaline phosphatase\|ALP]], ↑ GGT, ↑ direct bilirubin</span>
	- Mild transaminitis (or <span style="background:rgba(240, 200, 0, 0.2)">normal AST and ALT</span>)
- Lipid panel: <span style="background:rgba(240, 200, 0, 0.2)">hypercholesterolemia</span>
- PBC-specific autoantibodies
	- <span style="background:rgba(240, 200, 0, 0.2)">Antimitochondrial antibodies (AMA) (present in > 95% of patients)</span>
- Immunoglobulins (nonspecific)
	- ↑ IgM
- Biopsy
	- Because intrahepatic bile ducts are concentrated in the periportal regions, histopathology demonstrates <span style="background:rgba(240, 200, 0, 0.2)">periductal fibrosis</span> predominantly in those regions.![L31737.jpg](/img/user/appendix/L31737.jpg)
# Treatment
---
## General principles
- Start pharmacotherapy with ursodeoxycholic acid for all patients.
- <span style="background:rgba(240, 200, 0, 0.2)">Offer supportive care, including management of cholestasis-associated pruritus.</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Liver transplantation is necessary if liver [[USMLE/GI/Cirrhosis\|cirrhosis]] is advanced.</span>
## Pharmacotherapy
- First-line: ursodeoxycholic acid (UDCA, ursodiol): a hydrophilic, nontoxic bile acid with immunomodulatory, anti-inflammatory, choleretic, and cytoprotective effects
	- <span style="background:rgba(240, 200, 0, 0.2)">Slows disease progression</span> and development of complications (e.g., esophageal varices)
	- Prolongs transplant-free and overall survival
	- Also used in [[USMLE/GI/Primary sclerosing cholangitis\|primary sclerosing cholangitis]], cholestasis of [[USMLE/Reproductive/Pregnancy\|pregnancy]], and small cholesterol stones
